TY - JOUR T1 - Global projections of lives saved from COVID-19 with universal mask use JF - medRxiv DO - 10.1101/2020.10.08.20209510 SP - 2020.10.08.20209510 AU - Emmanuela Gakidou AU - David M. Pigott AU - Christopher E. Troeger AU - Erin N. Hulland AU - Robert C. Reiner, Jr AU - Christopher Adolph AU - Aleksandr Y. Aravkin AU - Steven D. Bachmeier AU - Bree Bang-Jensen AU - Ryan M. Barber AU - Catherine Bisignano AU - Sabina Bloom AU - Austin Carter AU - Emma Castro AU - Suman Chakrabarti AU - Jhilik Chattopadhyay AU - Christine Chen AU - Rebecca M. Cogen AU - James K. Collins AU - Emily Combs AU - Natalie Maria Cormier AU - Xiaochen Dai AU - William James Dangel AU - Amanda Deen AU - Samuel B. Ewald AU - Abraham D. Flaxman AU - Nancy Fullman AU - Gaorui Guo AU - Kathryn Hackman AU - Jiawei He AU - Nathaniel J. Henry AU - Casey Johanns AU - Samantha Leigh Larson AU - Alice Lazzar-Atwood AU - Kate E. LeGrand AU - Haley Lescinsky AU - Stephen S. Lim AU - Emily Linebarger AU - Rafael Lozano AU - Rui Ma AU - Beatrice Magistro AU - Johan C. Månsson AU - Laurie B. Marczak AU - Molly K. Miller-Petrie AU - Ali H. Mokdad AU - Meghan D. Mooney AU - Christopher M. Odell AU - James K. O’Halloran AU - Samuel M. Ostroff AU - Maja Pasovic AU - Disha J. Patel AU - Louise Penberthy AU - Rebecca E. Ramshaw AU - Gregory A. Roth AU - David H. Shaw AU - Brittney S. Sheena AU - Aleksei Sholokhov AU - Reed J. D. Sorensen AU - Gianna Sparks AU - Emma Elizabeth Spurlock AU - Michelle L. Subart AU - Ally Walker AU - Alexandrea Watson AU - Catherine A. Welgan AU - Kirsten E. Wiens AU - Lauren Woyczynski AU - Liming Xu AU - Simon I. Hay AU - Michael Brauer AU - Theo Vos AU - Christopher J. L. Murray AU - IHME COVID-19 Forecasting Team Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/18/2020.10.08.20209510.abstract N2 - BACKGROUND Social distancing mandates (SDM) have reduced health impacts from COVID-19 but also resulted in economic downturns that have led many nations to relax SDM. Until deployment of an efficacious and equitable vaccine, intervention options to reduce COVID-19 mortality and minimize restrictive SDM are sought by society.METHODS A susceptible-exposed-infectious-recovered (SEIR) deterministic transmission model was parameterized with data on reported deaths, cases, and select covariates to predict infections and deaths from COVID-19 through March 01, 2021. We explore three scenarios: a “non-adaptive” scenario where neither mask use or SDM adapt to changing conditions, a “reference” where current national levels of mask use are maintained and SDM reintroduced when deaths rise, and an increase in mask use to 95% coverage levels (“universal mask”). We reviewed published studies to set priors on the magnitude of reduction in transmission through increasing mask use.RESULTS Mask use was estimated at 59.0% of people globally on October 19, 2020. Universal mask use could avert 733,310 deaths (95% UI 385,981 to 1,107,759) between October 27, 2020 and March 01, 2021, the difference between the predicted 2.95 million deaths (95% UI 2.70 to 3.35) in the reference scenario and 2.22 million deaths (95% UI 2.00 to 2.45) in the universal mask scenario over this time period.CONCLUSIONS The cumulative toll of the COVID-19 pandemic could be substantially reduced by the universal adoption of masks before the availability of a vaccine. This low-cost, low-barrier policy, whether customary or mandated, has enormous health benefits with presumed marginal economic costs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Bill & Melinda Gates Foundation and Bloomberg Philanthropies. The funders of the study had no role in study design, data collection, data analysis, data interpretation, writing of the final report, or decision to publish. The corresponding author had full access to all of the data in the study and had final responsibility for the decision to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We only use data collected by other entities.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available to researchers and where not freely available, information on how to access the data is provided. ER -